What is a stock summary page? Click here for an overview.
Business Description
IRIDEX Corp
NAICS : 334510
SIC : 3845
ISIN : US4626841013
Description
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.51 | |||||
| Equity-to-Asset | 0.07 | |||||
| Debt-to-Equity | 2.21 | |||||
| Debt-to-EBITDA | -0.68 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.89 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.4 | |||||
| 3-Year EBITDA Growth Rate | -3.4 | |||||
| 3-Year EPS without NRI Growth Rate | -16.7 | |||||
| 3-Year Book Growth Rate | -55.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.22 | |||||
| 9-Day RSI | 50.45 | |||||
| 14-Day RSI | 45.08 | |||||
| 3-1 Month Momentum % | -24.59 | |||||
| 6-1 Month Momentum % | -19.3 | |||||
| 12-1 Month Momentum % | -54.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 134.63 | |||||
| Days Sales Outstanding | 47.14 | |||||
| Days Payable | 82.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | -28.34 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.07 | |||||
| Operating Margin % | -17.06 | |||||
| Net Margin % | -18.31 | |||||
| FCF Margin % | -15 | |||||
| ROE % | -178.37 | |||||
| ROA % | -28.01 | |||||
| ROIC % | -44.26 | |||||
| 3-Year ROIIC % | 48.92 | |||||
| ROC (Joel Greenblatt) % | -114.72 | |||||
| ROCE % | -50.96 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.33 | |||||
| PB Ratio | 7.31 | |||||
| EV-to-EBIT | -2.34 | |||||
| EV-to-EBITDA | -2.82 | |||||
| EV-to-Revenue | 0.4 | |||||
| EV-to-Forward-Revenue | 0.73 | |||||
| EV-to-FCF | -2.66 | |||||
| Price-to-GF-Value | 0.48 | |||||
| Price-to-Median-PS-Value | 0.23 | |||||
| Earnings Yield (Greenblatt) % | -42.74 | |||||
| FCF Yield % | -46.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IRIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IRIDEX Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 48.669 | ||
| EPS (TTM) ($) | -0.54 | ||
| Beta | 0.46 | ||
| 3-Year Sharpe Ratio | -0.56 | ||
| 3-Year Sortino Ratio | -0.84 | ||
| Volatility % | 38.44 | ||
| 14-Day RSI | 45.08 | ||
| 14-Day ATR ($) | 0.109961 | ||
| 20-Day SMA ($) | 1.027625 | ||
| 12-1 Month Momentum % | -54.3 | ||
| 52-Week Range ($) | 0.782 - 3.65 | ||
| Shares Outstanding (Mil) | 16.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IRIDEX Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IRIDEX Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IRIDEX Corp Frequently Asked Questions
What is IRIDEX Corp(IRIX)'s stock price today?
The current price of IRIX is $0.95. The 52 week high of IRIX is $3.65 and 52 week low is $0.78.
When is next earnings date of IRIDEX Corp(IRIX)?
The next earnings date of IRIDEX Corp(IRIX) is 2025-05-14 Est..
Does IRIDEX Corp(IRIX) pay dividends? If so, how much?
IRIDEX Corp(IRIX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers